CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands |
12 Months Ended |
Dec. 31, 2015 |
Dec. 31, 2014 |
Dec. 31, 2013 |
| Net service revenue |
$ 1,280,541
|
$ 1,204,554
|
$ 1,249,344
|
| Cost of service, excluding depreciation and amortization |
725,915
|
691,061
|
717,996
|
| General and administrative expenses: |
|
|
|
| Salaries and benefits |
279,425
|
292,497
|
302,564
|
| Non-cash compensation |
11,824
|
5,597
|
6,519
|
| Other |
161,186
|
143,644
|
164,991
|
| Provision for doubtful accounts |
14,053
|
16,294
|
15,882
|
| Depreciation and amortization |
20,036
|
28,307
|
36,871
|
| U.S. Department of Justice settlement |
0
|
0
|
150,000
|
| Asset impairment charge |
77,268
|
3,107
|
9,492
|
| Operating expenses |
1,289,707
|
1,180,507
|
1,404,315
|
| Operating (loss) income |
(9,166)
|
24,047
|
(154,971)
|
| Other income (expense): |
|
|
|
| Interest income |
71
|
94
|
54
|
| Interest expense |
(10,783)
|
(8,217)
|
(4,412)
|
| Equity in earnings from equity method investments |
9,823
|
2,991
|
1,520
|
| Miscellaneous, net |
9,747
|
2,061
|
4,334
|
| Total other income (expense), net |
8,858
|
(3,071)
|
1,496
|
| (Loss) income before income taxes |
(308)
|
20,976
|
(153,475)
|
| Income tax (expense) benefit |
(2,004)
|
(7,671)
|
58,773
|
| (Loss) income from continuing operations |
(2,312)
|
13,305
|
(94,702)
|
| Discontinued operations, net of tax |
0
|
(216)
|
(3,073)
|
| Net (loss) income |
(2,312)
|
13,089
|
(97,775)
|
| Net loss (income) attributable to noncontrolling interests |
(709)
|
(313)
|
1,597
|
| Net (loss) income attributable to Amedisys, Inc. |
$ (3,021)
|
$ 12,776
|
$ (96,178)
|
| Basic earnings per common share: |
|
|
|
| (Loss) income from continuing operations attributable to Amedisys, Inc. common stockholders |
$ (0.09)
|
$ 0.40
|
$ (2.98)
|
| Discontinued operations, net of tax |
0.00
|
(0.01)
|
(0.10)
|
| (Loss) income attributable to Amedisys, Inc. common stockholders |
$ (0.09)
|
$ 0.39
|
$ (3.08)
|
| Weighted average shares outstanding |
33,018
|
32,301
|
31,247
|
| Diluted earnings per common share: |
|
|
|
| (Loss) income from continuing operations attributable to Amedisys, Inc. common stockholders |
$ (0.09)
|
$ 0.40
|
$ (2.98)
|
| Discontinued operations, net of tax |
0.00
|
(0.01)
|
(0.10)
|
| (Loss) income attributable to Amedisys, Inc. common stockholders |
$ (0.09)
|
$ 0.39
|
$ (3.08)
|
| Weighted average shares outstanding |
33,018
|
32,823
|
31,247
|
| Amounts attributable to Amedisys, Inc. common stockholders: |
|
|
|
| (Loss) income from continuing operations |
$ (3,021)
|
$ 12,992
|
$ (93,105)
|
| Discontinued operations, net of tax |
0
|
(216)
|
(3,073)
|
| Net (loss) income attributable to Amedisys, Inc. |
$ (3,021)
|
$ 12,776
|
$ (96,178)
|